Direktorat Registrasi ObatValid

TECENTRIQ

Claim this product
BPOM Number
DKI2157509949B1
Approved
19 June 2025
Expiry
26 May 2026
Form
LARUTAN KONSENTRAT UNTUK INFUS

About This Registration

TECENTRIQ is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2157509949B1. Its current registration status is Valid, with the licence valid until 26 May 2026. The product is registered to MENARINI INDRIA LABORATORIES - INDONESIA. BPOM first approved this registration in June 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 1 VIAL @ 14 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

ATEZOLIZUMAB

Market Intelligence

Owner Portfolio
MENARINI INDRIA LABORATORIES - INDONESIA holds 98 BPOM registrations
Manufacturer Scale
MENARINI INDRIA LABORATORIES - INDONESIA produces 98 registered products
Registration Age
Registered for 1 year, 3 months
Expiry Status
Expired 122 days ago

FDA Cross-Reference

via openFDA
Generic Name
ATEZOLIZUMAB
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from MENARINI INDRIA LABORATORIES - INDONESIA

ITOVEBI

-DKI2657512117B1
Valid
Approved: Jul 22, 2026TABLET SALUT SELAPUT
View product →

ITOVEBI

-DKI2657512117A1
Valid
Approved: Jul 22, 2026TABLET SALUT SELAPUT
View product →

OCREVUS SC

-DKI2657511943A1
Valid
Approved: Apr 13, 2026LARUTAN INJEKSI
View product →

VABYSMO

-DKI2357511343A2
Valid
Approved: May 9, 2026LARUTAN INJEKSI
View product →

PROGYNOVA

-DKI2615901316A1
Valid
Approved: Mar 11, 2026TABLET SALUT GULA
View product →

Products in the same class

PARACETAMOL

-GBL2605069636B1
Valid
Approved: Apr 24, 2026DROPS
DEXA MEDICA - INDONESIA
View product →

ERYSANBE

-DKL7822225638A1
Valid
Approved: Dec 23, 2025SIRUP KERING
SANBE FARMA
View product →

GLIMEPIRIDE

-GKL2544412010A1
Valid
Approved: Nov 12, 2025TABLET
KIMIA FARMA TBK. - INDONESIA
View product →

COLCHICINE

-GKL1913321410A1
Valid
Approved: Mar 12, 2025TABLET
LAPI LABORATORIES - INDONESIA
View product →

SILDENAFIL CITRATE

-GKL2043006917B1
Valid
Approved: Feb 27, 2025TABLET SALUT SELAPUT
NULAB PHARMACEUTICAL INDONESIA - INDONESIA
View product →
1